Ronald Christopher Roberts

7PUBLICATIONS
34CO-AUTHORS
Molecular targetsMedical physiology not elsewhere classifiedPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 22, 2026
Modulating the VIP-VIPR pathway reprograms CAR T cells for superior antitumor efficacy in preclinical cancer models.

|May 01, 2023
Disseminated Peritoneal Tuberculosis Initially Misdiagnosed as Nephrogenic Ascites.

Lauren Crossman, Christopher Ronald Funk, Sheetal Kandiah

|Jun 10, 2022
KIT Mutations Correlate with Higher Galectin Levels and Brain Metastasis in Breast and Non-Small Cell Lung Cancer.

Avery T Funkhouser, Alexander M Strigenz, Bailey B Blair

|Jan 27, 2022
PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity.

Christopher Ronald Funk, Shuhua Wang, Kevin Z Chen

|Oct 13, 2021
Increased Circulating Levels of Galectin Proteins in Patients with Breast, Colon, and Lung Cancer.

Bailey B Blair, Avery T Funkhouser, Jane L Goodwin

|Apr 09, 2020
Rare missense variant p.Ala505Ser in the ZAK protein observed in a patient with split-hand/foot malformation from a non-consanguineous pedigree.

Christopher Ronald Funk, Elizabeth S Huey, Melanie M May

Pageof 2

Frequent Collaborators

2 joint publications

Julie C Martin

2 joint publications

Anna V Blenda

2 joint publications

Sruthi Ravindranathan

2 joint publications

Edmund K Waller